Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 1
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Vaccine Vectors Harnessing the Power of Cytomegaloviruses.
Ynga-Durand MA, Dekhtiarenko I, Cicin-Sain L. Ynga-Durand MA, et al. Vaccines (Basel). 2019 Oct 17;7(4):152. doi: 10.3390/vaccines7040152. Vaccines (Basel). 2019. PMID: 31627457 Free PMC article. Review.
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations.
Jacobsen H, Strengert M, Maaß H, Ynga Durand MA, Katzmarzyk M, Kessel B, Harries M, Rand U, Abassi L, Kim Y, Lüddecke T, Metzdorf K, Hernandez P, Ortmann J, Heise JK, Castell S, Gornyk D, Glöckner S, Melhorn V, Kemmling Y, Lange B, Dulovic A, Marsall P, Häring J, Junker D, Schneiderhan-Marra N, Hoffmann M, Pöhlmann S, Krause G, Cicin-Sain L. Jacobsen H, et al. Among authors: ynga durand ma. Sci Rep. 2022 Nov 18;12(1):19858. doi: 10.1038/s41598-022-22552-y. Sci Rep. 2022. PMID: 36400804 Free PMC article.
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M, Bertoglio F, Steinke S, Heine PA, Ynga-Durand MA, Maass H, Sammartino JC, Cassaniti I, Zuo F, Du L, Korn J, Milošević M, Wenzel EV, Krstanović F, Polten S, Pribanić-Matešić M, Brizić I, Baldanti F, Hammarström L, Dübel S, Šustić A, Marcotte H, Strengert M, Protić A, Piralla A, Pan-Hammarström Q, Čičin-Šain L, Hust M. Schubert M, et al. Among authors: ynga durand ma. BMC Med. 2022 Mar 3;20(1):102. doi: 10.1186/s12916-022-02312-5. BMC Med. 2022. PMID: 35236358 Free PMC article.
Erratum to "Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome".
Alonso-Bello CD, Jiménez-Martínez MDC, Vargas-Camaño ME, Hierro-Orozco S, Ynga-Durand MA, Berrón-Ruiz L, Alcántara-Montiel JC, Santos-Argumedo L, Andrea Herrera-Sánchez D, Lozano-Patiño F, Castrejón-Vázquez MI. Alonso-Bello CD, et al. Among authors: ynga durand ma. Case Reports Immunol. 2021 Jan 31;2021:2361360. doi: 10.1155/2021/2361360. eCollection 2021. Case Reports Immunol. 2021. PMID: 33628541 Free PMC article.
Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome.
Alonso-Bello CD, Jiménez-Martínez MDC, Vargas-Camaño ME, Hierro-Orozco S, Ynga-Durand MA, Berrón-Ruiz L, Alcántara-Montiel JC, Santos-Argumedo L, Herrera-Sánchez DA, Lozano-Patiño F, Castrejón-Vázquez MI. Alonso-Bello CD, et al. Among authors: ynga durand ma. Case Reports Immunol. 2019 Jul 4;2019:6357256. doi: 10.1155/2019/6357256. eCollection 2019. Case Reports Immunol. 2019. PMID: 31355024 Free PMC article.